Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.814 USD | -2.98% | -4.55% | +59.61% |
06/05 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
10/04 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.61% | 1.16Cr | |
+5.66% | 11TCr | |
+11.23% | 11TCr | |
-2.53% | 2.19TCr | |
-12.15% | 2.23TCr | |
-7.66% | 1.86TCr | |
-36.52% | 1.81TCr | |
-10.09% | 1.7TCr | |
+3.33% | 1.37TCr | |
+36.58% | 1.24TCr |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Chemomab Therapeutics : Oppenheimer Initiates Coverage on Chemomab Therapeutics With Outperform Rating, $42 Price Target